
1. n engl j med. 2016 jun 23;374(25):2453-64. doi: 10.1056/nejmoa1513137.

a worldwide map plasmodium falciparum k13-propeller polymorphisms.

ménard d(1), khim n(1), beghain j(1), adegnika aa(1), shafiul-alam m(1), amodu
o(1), rahim-awab g(1), barnadas c(1), berry a(1), boum y(1), bustos md(1), cao
j(1), chen jh(1), collet l(1), cui l(1), thakur gd(1), dieye a(1), djallé d(1),
dorkenoo ma(1), eboumbou-moukoko ce(1), espino fe(1), fandeur t(1),
ferreira-da-cruz mf(1), fola aa(1), fuehrer hp(1), hassan am(1), herrera s(1),
hongvanthong b(1), houzé s(1), ibrahim ml(1), jahirul-karim m(1), jiang l(1),
kano s(1), ali-khan w(1), khanthavong m(1), kremsner pg(1), lacerda m(1), leang
r(1), leelawong m(1), li m(1), lin k(1), mazarati jb(1), ménard s(1), morlais
i(1), muhindo-mavoko h(1), musset l(1), na-bangchang k(1), nambozi m(1), niaré
k(1), noedl h(1), ouédraogo jb(1), pillai dr(1), pradines b(1), quang-phuc b(1), 
ramharter m(1), randrianarivelojosia m(1), sattabongkot j(1), sheikh-omar a(1),
silué kd(1), sirima sb(1), sutherland c(1), syafruddin d(1), tahar r(1), tang
lh(1), touré oa(1), tshibangu-wa-tshibangu p(1), vigan-womas i(1), warsame m(1), 
wini l(1), zakeri s(1), kim s(1), eam r(1), berne l(1), khean c(1), chy s(1), ken
m(1), loch k(1), canier l(1), duru v(1), legrand e(1), barale jc(1), stokes b(1),
straimer j(1), witkowski b(1), fidock da(1), rogier c(1), ringwald p(1), ariey
f(1), mercereau-puijalon o(1); karma consortium.

collaborators: aboubacar m, acuña jh, andrianaranjaka v, arévalo-herrera m,
aristide aa, asih pb, bobogare a, brey pt, chaijaroenkul w, chen sb, chileshe j, 
chobson p, cojean s, coulibaly b, deloron p, ding xc, djadid nd, diop g, djimdé
a, doumbo ok, durand s, fall b, fan y, fortes f, henriques g, hetzel mw,
honkpehedji yj, hubert v, inocêncio da luz r, iwagami m, javati s, karema c,
kuehn a, lamine mm, lescano ag, lepère jf, lötsch f, lu f, luchavez js, lutumba
p, madamet m, malunga p, mara se, marantina ss, mohon an, monteiro w, mueller i, 
muhamud p, mwanga-amumpaire j, nguitragool w, nolder d, nsango s, nyehangane d,
olaniyan s, ouedraogo a, piola p, pirahmadi s, raeisi a, rodrigues gomes l, silai
r, fa, soulama i, texier g, thiam a, timinao l, umulisa n, vallejo af, van
geertruyden jp, wang z, zongo i.

author information: 
(1)the authors' affiliations listed supplementary appendix , available
at nejm.org.

comment in
    n engl j med. 2016 jun 23;374(25):2492-3.

background: recent gains reducing global burden malaria threatened 
by emergence plasmodium falciparum resistance artemisinins. the
discovery mutations portions p. falciparum gene encoding kelch
(k13)-propeller domains major determinant resistance provided
opportunities monitoring resistance global scale.
methods: analyzed k13-propeller sequence polymorphism 14,037 samples
collected 59 countries malaria endemic. samples
(84.5%) obtained patients treated sentinel sites used for
nationwide surveillance antimalarial resistance. evaluated emergence
and dissemination mutations haplotyping neighboring loci.
results: identified 108 nonsynonymous k13 mutations, showed marked
geographic disparity frequency distribution. asia, 36.5% the
k13 mutations distributed within two areas--one cambodia, vietnam, and
laos western thailand, myanmar, china--with overlap. in
africa, observed broad array rare nonsynonymous mutations not
associated delayed parasite clearance. gene-edited dd2 transgenic line
with a578s mutation, expresses frequently observed african
allele, found susceptible artemisinin vitro ring-stage
survival assay.
conclusions: evidence artemisinin resistance found outside southeast
asia china, resistance-associated k13 mutations confined. the
common african a578s allele associated clinical vitro
resistance artemisinin, many african mutations appear neutral.
(funded institut pasteur paris others.).

doi: 10.1056/nejmoa1513137 
pmcid: pmc4955562
pmid: 27332904  [indexed medline]

